Case Age Gender Previous treatment Previous treatment Systemic treatment IGA W0 IGA W6 IGA W12 IGA W33 IGA W33 IGA W33 IGA W33 IGA W52 IGA W52 IGA W52 IGA W52 IGA W52
1 28 F Topical TET ISO Topical TET ISO ISO 5mg/day OCP 4 3 1 0 0 0 0 0 0 0 0 0
2 27 F Topical TET Topical TET ISO 5mg/day Levonogestrel IUD 4 2 2 0 0 0 0 0 0 0 0 0
3 18 M Topical TET ISO Topical TET ISO ISO 5mg/day 4 3 3 0 0 0 0 0 0 0 0 0
4 19 M Topical TET Topical TET ISO 5mg/day 3 2 1 0 0 0 0 0 0 0 0 0
5 20 F Topical Topical ISO 5mg/day 4 2 1 0 0 0 0 0 0 0 0 0
6 19 M Topical TET ISO Topical TET ISO TET 300mg/day,12wks 3 2 1 1 1 1 1 1 1 1 1 1
7 18 M Topical TET ISO Topical TET ISO ISO 5mg/day 3 1 1 0 0 0 0 0 0 0 0 0
8 20 M Topical TET Topical TET ISO 5mg/day 4 2 1 0 0 0 0 0 0 0 0 0
9 20 F Topical TET ISO Topical TET ISO ISO 5mg/day OCP 4 2 1 0 0 0 0 0 0 0 0 0
10 24 F Topical TET Evra Topical TET Evra TET 300mg/day,12wks BCP 3 1 1 1 1 1 1 1 1 1 1 1
11 18 M Topical TET ISO Topical TET ISO ISO 5mg/day 3 2 2 0 0 0 0 0 0 0 0 0
12 17 M Topical Topical TET 300mg/day,12wks 3 2 1 1 1 1 1 1 1 1 1 1